Most bought biotechnology stocks in Q1 2018

See which Biotechnology stocks institutional investors increased the most in Q1 2018, measured as net growth in reported share positions from Q4 2017 into Q1 2018. Notable additions at the top of this list include MERUS N V (MRUS). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Explore more:

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
MRUSMERUS N V38,000$70410001
Net change in reported shares (all institutional filers) by symbol1 symbols with net change in reported shares from all institutional filers.0.0011.5K23.0K34.5K46.0KNet change in reported shares (all institutional filers)MRUSSymbol

Frequently asked questions about Most bought biotechnology stocks in Q1 2018

  • What are the most bought Biotechnology stocks in Q1 2018?

    The most bought biotechnology stocks in Q1 2018 are those with the largest increase in reported share counts across institutional investors compared to Q4 2017, based on SEC 13F filings.

  • Which biotechnology stocks did institutional investors added to the most in Q1 2018?

    Among filers in this sector, net additions were largest in companies such as MERUS N V (MRUS), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2017).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.